 fluorescent with single strand 2733.jpg "Our New Fluorescent mRNA")
The SINPAIN research project is on a mission to revolutionize the treatment of knee arthritis by developing a novel nanomedicine-based therapeutic. A newly released video clip explores the project’s innovative approach and the potentially life-changing benefits for individuals affected by the debilitating joint disorder, often referred to as degeneration osteoarthritis.
The animated video provides a comprehensive overview of the novel techniques and methodologies being developed by SINPAIN. This includes advanced therapy based on small interfering RNA (siRNA), the latest intraarticular hyaluronic acid (IA-HA) and nanocarrier technologies, and state-of-the-art machine learning methods.
The clip demonstrates how these advancements could alleviate the knee and pain associated with arthritis in one knee, and underscores the potential of the project’s research to reshape the future of osteoarthritis of the knee treatment.
Designed to be both informative and engaging, the video serves as a valuable resource for people affected by arthritis and knee pain, healthcare professionals, researchers, and anyone interested in understanding the trailblazing work being undertaken by SINPAIN.
“We are incredibly excited to share this video that delves into the complex science behind SINPAIN’s research in a manner that is accessible to all, highlighting the potential of the forthcoming research results to instigate a paradigm shift in osteoarthritis knee joint treatment and offer hope to millions of people worldwide”, says SINPAIN coordinator Dr Damien Dupin (CIDETEC).
The video is now available for viewing on the SINPAIN project website. For the latest updates about the work conducted in the project, please follow SINPAIN on LinkedIn.
About SINPAIN
The EU-funded research project SINPAIN aims to improve the quality of life for those affected by degenerative joint disease in knee. By developing a new generation of advanced, safe, efficient, and cost-effective nanotherapeutics based on siRNA, the project aims to alleviate the pain experienced by osteoarthritis knee patients worldwide and reduce the significant costs associated with the disease.
The project brings together a diverse and international team from twelve partner institutions located in Europe and the USA, fostering a collaborative and multidisciplinary approach to tackling this global health challenge.
